Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hao-Zhe Cao"'
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Tumor resistance is a global challenge for tumor treatment. Cancer stem cells (CSCs) are the main population of tumor cells for drug resistance. We have reported that high aldehyde dehydrogenase (ALDH) activity represents a functi
Externí odkaz:
https://doaj.org/article/177dac5222b547f4a23d35ac10baeeec
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107013 (2014)
Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) has recently been reported to be a marker of cancer stem cells (CSCs) in colorectal cancer (CRC), and the prognostic value of LGR5 in CRC has been evaluated in several studies. Howeve
Externí odkaz:
https://doaj.org/article/dda06dec8eaa4ae88086ee74c1d6d59f
Autor:
Hao Zhe Cao, Jie Hou
Publikováno v:
CHUNGGUKSA YONGU (The Journal of Chinese Historical Researches). 109:275-280
Publikováno v:
Cell Death & Disease
Cancer stem cells (CSCs), also known as tumor-initiating cells, contribute to tumorigenesis, resistance to chemoradiotherapy and recurrence in human cancers, suggesting targeting CSCs may represent a potential therapeutic strategy. Leucine-rich repea
Publikováno v:
Oncotarget
Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5), a seven transmembrane receptor known as a potential stem cell marker for intestinal crypts and hair follicles, has recently been found to be overexpressed in some types of human canc
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107013 (2014)
PLoS ONE
PLoS ONE
Objective Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) has recently been reported to be a marker of cancer stem cells (CSCs) in colorectal cancer (CRC), and the prognostic value of LGR5 in CRC has been evaluated in several studi
OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway
Publikováno v:
Cell Death & Disease
Octamer-binding transcription factor 4 (OCT4) is a key regulatory gene that maintains the pluripotency and self-renewal properties of embryonic stem cells. Although there is emerging evidence that it can function as oncogene in several cancers, the r